University Hospital, Toulouse

This study looked at two ways to treat otosclerosis, a condition that causes hearing loss. Thirty adults each tried a hearing aid for at least two months and then had surgery. The goal was to see which approach improved their quality of life more. The study was completed in Franc…

This study tested whether lixisenatide, a drug used for diabetes, could slow the worsening of movement problems in people with early Parkinson's disease. 156 participants received either the drug or a placebo alongside their usual Parkinson's medications. The goal was to see if l…

This study tested a special shoulder sling (EO31) in 25 adults who had a stroke within the last 6 months and had arm weakness. The goal was to see if the sling could help prevent shoulder pain and other complications. Researchers measured success by how well patients met personal…

This pilot study tested whether a care system designed to prevent iatrogenic dependency (loss of independence caused by hospitalization) is feasible for adults aged 70 and older. One hospital unit used the prevention program, while another provided routine care. The program inclu…

This study tested a new therapy for people who had a stroke and have trouble moving their arm. It combined imagining arm movements (motor imagery) with a gentle brain stimulation technique called TMS. The goal was to see if this combination could improve brain signals to the arm …

This study looked at how foot reflexology—a type of foot massage—affects the diaphragm, the main muscle used for breathing. Researchers measured brain activity and vital signs in 30 healthy adults to see if reflexology has a specific effect compared to a placebo. The goal was to …

This study surveyed 47 older adults (65+) in France to understand how much they know about cannabidiol (CBD) and whether they use it. The goal was to gather information to help guide safe CBD use and prevent potential side effects in this age group. Participants completed a quest…

This early-phase study tested whether a natural substance called apelin can improve how the body responds to insulin in people with type 2 diabetes. Nine adults with type 2 diabetes received apelin to measure changes in insulin sensitivity. The goal was to gather initial data, no…